Product NDC: | 0299-6100 |
Proprietary Name: | PLIAGLIS |
Non Proprietary Name: | lidocaine and tetracaine |
Active Ingredient(s): | 70; 70 mg/g; mg/g & nbsp; lidocaine and tetracaine |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0299-6100 |
Labeler Name: | Galderma Laboratories, L.P. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021717 |
Marketing Category: | NDA |
Start Marketing Date: | 20060629 |
Package NDC: | 0299-6100-10 |
Package Description: | 100 g in 1 TUBE (0299-6100-10) |
NDC Code | 0299-6100-10 |
Proprietary Name | PLIAGLIS |
Package Description | 100 g in 1 TUBE (0299-6100-10) |
Product NDC | 0299-6100 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | lidocaine and tetracaine |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20060629 |
Marketing Category Name | NDA |
Labeler Name | Galderma Laboratories, L.P. |
Substance Name | LIDOCAINE; TETRACAINE |
Strength Number | 70; 70 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE],Ester Local Anesthetic [EPC],Esters [Chemical/Ingredient],Local Anesthesia [PE] |